Find your next paid study

Case Comprehensive Cancer CenterNCT07044362

~$10 – $750

Actual pay is set by the research site.

Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)

To learn if the combination of niraparib and dostarlimab can help to control advanced cancer that has spread to the brain.

Brain Metastases

M.D. Anderson Cancer CenterNCT05700721

Actual pay is set by the research site.

The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

The Multi-OutcoMe EvaluatioN of radiation Therapy Using the Unity MR-Linac Study (MOMENTUM) is a multi-institutional, international registry facilitating evide…

OncologyBreast CancerProstate Cancer+35 more

~$10 – $1,125

Actual pay is set by the research site.

UMC UtrechtNCT04075305

Clinical Trial Optimizing Tumor Ablation for Liver Metastases: Rapid Tissue Analysis Allowing for Immediate Retreatment; Metabolic Imaging Biomarker Validation; and Predictive Genetic Signatures

This study will see whether collecting and analyzing needle biopsy samples from cancer liver metastases after a tumor ablation procedure will be able to identi…

Liver Metastases

Memorial Sloan Kettering Cancer CenterNCT04143516

Actual pay is set by the research site.

Observational

UAB 2507 - Randomized Phase II Study of Differential Margins in Single Isocenter Radiosurgery of Brain Metastases

Radiosurgery is the use of a focal high dose of radiation therapy to ablate or kill a tumor. This trial will enroll patients with brain metastases 4 cm or less…

Brain Metastases

University of Alabama at BirminghamNCT06857006

~$10 – $750

Actual pay is set by the research site.

EXCLAIM: Exploring Combined Local and Systemic Approaches In Brain Metastasis: a Multi-cohort Randomized Phase II Study Evaluating Initial Response to Systemic Therapy and Subsequent Integration of Stereotactic Radiosurgery in Patients With Low-risk Brain Metastases and Central Nervous System-active Systemic Therapy Options

To learn if consolidative stereotactic radiosurgery (cSRS) can help to control central nervous system (CNS) disease in patients who have brain metastases and h…

Brain Metastases

M.D. Anderson Cancer CenterNCT06649058

Actual pay is set by the research site.

Phase 1

Phase 1b/2 Trial of Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma

The goal of this interventional clinical trial is to provide proof-of-principle data for the biologic activity of defactinib in combination with avutometinib i…

Cutaneous MelanomaBrain Metastases

University of UtahNCT06194929

~$150 – $3,000

Actual pay is set by the research site.

Magnetic Resonance Imaging Biomarkers for Radiation-Induced Neurocognitive Decline Following Stereotactic Radiosurgery of Newly Diagnosed Brain Metastases: An Observational Pilot Study

Brain metastases are a source of much morbidity and mortality in adults with primary solid malignant tumors. With improvements in systemic therapy that prolong…

Brain MetastasesNeurocognitive DeficitWhite Matter Alterations+1 more

UNC Lineberger Comprehensive Cancer CenterNCT04073966

~$10 – $750

Actual pay is set by the research site.

Distribution of Lymph Node Metastases in Esophageal Carcinoma

Background: Lymph node status is an important prognostic parameter in esophageal carcinoma and an independent predictor of survival. Distribution of metastatic…

Esophageal NeoplasmsLymph Node Metastases

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)NCT03222895

~$10 – $1,125

Actual pay is set by the research site.

Clear Cell Renal Cell Cancer (ccRCC)Clear Cell Renal CarcinomaClear Cell Renal Cell Carcinoma Metastatic+7 more

A Phase II Study of Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases in Patients Previously Treated With Immune Checkpoint Inhibitors

This is a single-institution, phase 2 trial of zanzalintinib plus investigator-choice bone-strengthening agent in patients with metastatic renal cell carcinoma…

Kelly Fitzgerald, MDNCT07043608

~$75 – $3,000

Actual pay is set by the research site.

Lung Non-Small Cell CarcinomaMediastinal NeoplasmPleural Neoplasm+4 more

Phase II Trial of Lung Chemoemobolization

This phase II trial evaluates how well transarterial chemoembolization (TACE) works for treating patients with non-small cell lung cancer or lung metastases. T…

City of Hope Medical CenterNCT05672108

Actual pay is set by the research site.

Phase 4

Brain [18F]-FES PET/CT in the Diagnosis, Treatment Planning and Response Assessment of Brain Metastases in Patients With Estrogen-Receptor Positive Breast Cancer

The goal of this interventional study is to optimize the protocol of FES PET/CT in Estrogen Receptor positive Breast cancer patients with Brain metastases. Pat…

Breast CancerBrain Metastases